Skip to main content
TipRanks
Go Ultimate75% OFF

Hightide Therapeutics Inc (2511) Financial Statements

1 Followers

Hightide Therapeutics Inc Financial Overview

Hightide Therapeutics Inc's market cap is currently ¥1.79B. The company's EPS TTM is ¥-0.54; its P/E ratio is -4.64; Hightide Therapeutics Inc has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 0.00¥ 0.00¥ 0.00¥ 0.00¥ 0.00
Gross Profit¥ 0.00¥ 0.00¥ 0.00¥ 0.00¥ 0.00
Operating Income¥ -223.57M¥ -444.75M¥ -448.24M¥ -226.08M¥ -132.08M
EBITDA¥ -217.31M¥ -438.86M¥ -446.41M¥ -224.81M¥ -130.49M
Net Income¥ -244.97M¥ -381.79M¥ -939.31M¥ -190.24M¥ -221.15M
Balance Sheet
Cash & Short-Term Investments¥ 502.94M¥ 490.52M¥ 735.70M¥ 828.33M¥ 763.91M
Total Assets¥ 551.58M¥ 559.93M¥ 795.04M¥ 855.82M¥ 777.23M
Total Debt¥ 126.92M¥ 77.91M¥ 16.43M¥ 1.27B¥ 1.01B
Net Debt¥ -105.57M¥ -232.84M¥ -591.78M¥ 846.32M¥ 248.32M
Total Liabilities¥ 186.75M¥ 135.76M¥ 92.26M¥ 1.33B¥ 1.05B
Stockholders' Equity¥ 307.14M¥ 424.17M¥ 702.77M¥ -470.53M¥ -271.77M
Cash Flow
Free Cash Flow¥ -166.98M¥ -299.46M¥ -368.56M¥ -172.90M¥ -90.12M
Operating Cash Flow¥ -166.91M¥ -294.81M¥ -367.67M¥ -172.71M¥ -90.55M
Investing Cash Flow¥ -102.90M¥ -89.72M¥ 321.64M¥ -415.66M¥ 1.59M
Financing Cash Flow¥ 199.72M¥ 54.79M¥ 399.46M¥ 46.03M¥ 493.98M

Currency in CNY

Hightide Therapeutics Inc Earnings and Revenue History

-1.2B-800M-400M00 %0.4 %0.8 %1.2 %EarningsProfit Margin20212022202320242025RevenueEarningsProfit Margin

Hightide Therapeutics Inc Liabilities to Assets

0500M1B1.5B0 %60 %120 %180 %LiabilitiesLiabilities to Assets20212022202320242025AssetsLiabilitiesLiabilities to Assets

Hightide Therapeutics Inc Cash Flow

-500M-250M0250M500M750M20212022202320242025OperatingInvestingFinancing

Hightide Therapeutics Inc Forecast EPS vs Actual EPS

-0.6-0.5-0.4-0.3-0.2Q2 24Q4 24Q2 25Q4 25Q2 26Q4 26EPS EstimateBeatMiss